Results 51 to 60 of about 100,230 (154)

Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2015
Angioedema is an asymmetric non-pitting oedema on face, lips, tongue and mucous membranes; any delay in diagnosis and treatment can be fatal. Treatment with lisinopril as an angiotensin converting enzyme (ACE) inhibitor, can be a reason of angioedema ...
Eray Atalay   +6 more
doaj  

Inhibition of central angiotensin converting enzyme exerts anxiolytic effects by decreasing brain oxidative stress [PDF]

open access: yesJournal of Medical Biochemistry, 2011
This study investigated the effects of angiotensin II and captopril intracerebroventricular administration on anxiety status and brain oxidative stress.
Ciobica Alin   +4 more
doaj  

Antioxidant activity of inhibitor of angiotensin-converting enzyme in kidney

open access: yesRUDN Journal of Medicine, 2009
The influence of inhibition of angiotensin-converting enzyme on free-radical processes in kidney cell is investigated at different models of acute renal failure. It is established antioxidant effect of captopril in kidneys of rats.
Y A Belous   +2 more
doaj  

[Prevention with angiotensin-converting enzyme (ACE) inhibitors].

open access: yesZeitschrift fur Kardiologie, 1993
Preventive therapy by angiotensin-converting-enzyme (ACE) inhibitors is considered in hypertension and, more recently, in chronic heart failure. The mechanism of action of ACE-inhibitors is complex; most extensively studied, however, is their inhibitory effect on angiotensin-II production.
Ertl, G   +3 more
openaire   +3 more sources

Preoperative Angiotensin-Converting Enzyme Inhibitor Use and Its Effect on Intraoperative Hypotension in Non-cardiac Surgeries: A Meta-Analysis. [PDF]

open access: yesCureus
Ahsan M   +9 more
europepmc   +1 more source

Risk factors for angiotensin converting enzyme inhibitor angioedema in a South African population. [PDF]

open access: yesFront Allergy
Day C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy